Log in to save to my catalogue

Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human...

Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67051343

Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis

About this item

Full title

Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis

Publisher

United States

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2009-03, Vol.106 (11), p.4355-4359

Language

English

Formats

Publication information

Publisher

United States

More information

Scope and Contents

Contents

Mechanisms of action as well as cellular targets of glatiramer acetate (GA) in multiple sclerosis (MS) are still not entirely understood. IL-1beta is present in CNS-infiltrating macrophages and microglial cells and is an important mediator of inflammation in experimental autoimmune encephalitis (EAE), the MS animal model. A natural inhibitor of IL-...

Alternative Titles

Full title

Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_67051343

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67051343

Other Identifiers

E-ISSN

1091-6490

DOI

10.1073/pnas.0812183106

How to access this item